Onyx Healthcare, Inc. (6569) AI Stock Analysis

Onyx Healthcare, Inc.

(TPEx:6569)

Select Model

Rating:56Neutral

Price Target:TWD 84.00▲(5.53% Upside)

Action:initiatedcoverage

Date:11/09/26

Onyx Healthcare scores in the middle of the range. Its financial foundation is genuinely solid — very low leverage, 73% equity-funded assets, and a strong rebound in free cash flow — but three consecutive years of margin compression have left operating margin at just 4%, with net income increasingly dependent on non-operating items and ROE down to 7.1%. Technicals compound the caution: the price sits well below all major moving averages with a negative MACD, confirming a persistent downtrend, though deeply oversold RSI and Stochastic readings suggest selling may be stretched. Valuation offers partial support via a 3.68% dividend yield that is comfortably cash-covered, while a P/E of 19.2 looks only fair against declining earnings quality. The balance sheet means little financial risk, but a sustained re-rating likely requires evidence that core operating profitability is recovering.

Positive Factors

Conservative Balance SheetLow leverage reduces balance-sheet strain and preserves flexibility to fund operations, invest in healthcare computing products, or withstand weaker demand. This financial resilience is a durable advantage because modest debt lessens refinancing exposure and limits interest-related pressure on future earnings.

Negative Factors

Sustained Revenue DeclineThree consecutive years of declining revenue indicate sustained pressure on demand or commercial execution rather than a single-quarter fluctuation. If this trend persists, lower scale can limit operating leverage, reduce investment capacity, and make recovery in earnings power more difficult.

Onyx Healthcare, Inc. (6569) vs. SPDR S&P 500 ETF (SPY)

Market Cap: TWD 3.40B
Dividend Yield: 3.77%
Average Volume (3M): 33.14K
Price to Earnings (P/E): 18.6
Beta (1Y): 0.58
Revenue Growth: 3.93%
EPS Growth: 28.67%
Country: TW
Employees: 120
Sector: General
Sector Strength: 55
Industry: Medical - Healthcare Information Services

Onyx Healthcare, Inc. Business Overview & Revenue Model

Company Description

Onyx Healthcare Inc. is a dedicated Taiwanese firm specializing in medical information technology. The company focuses on the entire lifecycle—from conceptual design and manufacturing to the commercial distribution—of medical computing hardware and p...

Onyx Healthcare, Inc. Financial Statement Overview

Summary

A tale of two halves. The balance sheet (79) is the standout: equity funds roughly 73% of assets, debt-to-equity sits at just 0.19, and book value has compounded steadily since 2020, leaving minimal solvency risk. Cash flow (68) also improved, with operating cash flow up to NT$164.2m and free cash flow to NT$149.9m, converting about 91% of net income into cash. The weak link is the income statement (48): although revenue grew 5.8% to NT$1.31bn, operating margin collapsed to 4.0% from 11.6% and 20.7% in the prior two years, net income fell 38% to NT$111.7m, and reported profit now exceeds operating profit — meaning the bottom line leans on non-operating items. Return on equity has halved since 2023 to 7.1%.

Income Statement

48Neutral

Balance Sheet

79Positive

Cash Flow

68Positive

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.45B	1.31B	1.24B	1.49B	1.60B	1.20B
Gross Profit	477.22M	434.02M	456.27M	556.14M	472.31M	363.73M
EBITDA	103.86M	74.05M	164.37M	332.78M	271.07M	170.68M
Net Income	183.65M	111.70M	180.91M	255.26M	202.96M	127.55M
Balance Sheet
Total Assets	2.36B	2.15B	2.11B	2.05B	1.97B	1.70B
Cash, Cash Equivalents and Short-Term Investments	267.98M	382.50M	332.83M	409.78M	336.10M	193.02M
Total Debt	387.16M	292.84M	250.98M	206.74M	191.92M	315.55M
Total Liabilities	813.54M	583.59M	553.43M	527.66M	566.02M	667.17M
Stockholders Equity	1.55B	1.57B	1.54B	1.51B	1.39B	1.03B
Cash Flow
Free Cash Flow	-48.74M	149.87M	117.43M	282.51M	146.74M	-278.77M
Operating Cash Flow	-30.20M	164.16M	124.52M	350.49M	161.79M	17.13M
Investing Cash Flow	-94.83M	-32.51M	-52.98M	-184.36M	-31.03M	-332.06M
Financing Cash Flow	3.14M	-79.95M	-120.67M	-128.54M	6.03M	109.89M

Onyx Healthcare, Inc. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

TW:6569 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TW:3046	71Outperform	TWD 3.92B	10.16	―	5.96%	31.68%	27.27%
TW:3556	64Neutral	TWD 3.65B	14.40	―	3.15%	27.26%	133.00%
TW:6569	56Neutral	TWD 3.44B	18.64	―	3.77%	3.93%	28.67%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
TW:3594	49Neutral	TWD 3.85B	33.07	―	0.95%	30.92%	271.46%
TW:6612	43Neutral	TWD 3.60B	33.24	―	0.44%	12.00%	2.68%

* General Sector Average

Performance Comparison

TW:6569 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TW:6569	Onyx Healthcare, Inc.	79.60	-30.31	-27.58%
TW:3046	Aopen Incorporated	50.30	3.55	7.59%
TW:3556	eGalax_eMPIA Technology Inc.	61.90	23.95	63.09%
TW:3594	ARBOR Technology Corp.	41.90	1.37	3.38%
TW:6612	ICARES Medicus Inc	68.50	-11.20	-14.06%
TW:7821	Mitac Digital Technology Corporation	31.45	-25.82	-45.09%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 09, 2026

Onyx Healthcare, Inc. AI Stock Analysis